舰旗 发表于 2025-3-25 03:36:56

http://reply.papertrans.cn/19/1874/187399/187399_21.png

心神不宁 发表于 2025-3-25 09:28:09

http://reply.papertrans.cn/19/1874/187399/187399_22.png

OREX 发表于 2025-3-25 12:52:47

http://reply.papertrans.cn/19/1874/187399/187399_23.png

Friction 发表于 2025-3-25 16:10:49

https://doi.org/10.1007/978-3-658-18524-4l response exceed 90% and complete response (CR) more than 50% in some studies. Unfortunately, despite higher rates of CR, relapse rates remain high suggesting that persistent disease may not be measured by current techniques. Traditionally, response rates were defined by urine and serum protein ele

Indurate 发表于 2025-3-25 22:51:43

Biological Mechanisms of Minimal Residual Disease and Systemic Cancer978-3-319-97746-1Series ISSN 0065-2598 Series E-ISSN 2214-8019

APRON 发表于 2025-3-26 00:22:46

http://reply.papertrans.cn/19/1874/187399/187399_26.png

救护车 发表于 2025-3-26 07:46:30

http://reply.papertrans.cn/19/1874/187399/187399_27.png

返老还童 发表于 2025-3-26 10:57:10

http://reply.papertrans.cn/19/1874/187399/187399_28.png

Leisureliness 发表于 2025-3-26 14:54:07

Advances in Experimental Medicine and Biologyhttp://image.papertrans.cn/b/image/187399.jpg

acolyte 发表于 2025-3-26 19:31:37

Book 2018ematological malignancies. It reports also on technological advancements for monitoring MRD, derived from mechanistic insights. Chapters in solid and hematological malignancies address stem cell biology, genetics, epigenetics and micro-environmental regulation of dormant MRD. Novel insight into tech
页: 1 2 [3] 4 5
查看完整版本: Titlebook: Biological Mechanisms of Minimal Residual Disease and Systemic Cancer; Julio A.‘Aguirre-Ghiso Book 2018 Springer Nature Switzerland AG 201